Emboline, Inc.

About Emboline, Inc.

Emboline is a medical device company focused on developing embolic protection solutions for interventional heart procedures. Their mission is to provide comprehensive brain and body protection during such procedures to prevent stroke, cognitive decline, acute kidney injury, and other ischemic complications caused by embolic debris.

Products & Services

Emboliner Total-Body Embolic Protection System:A device used during interventional heart procedures to capture and remove embolic debris from the bloodstream, offering comprehensive brain and body protection with a dual-layer Nitinol mesh filter and integrated port for high blood flow and debris capture.

Specialties

Embolic Protection Interventional Heart Procedures Transcatheter Aortic Valve Replacement (TAVR)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Growth Capital T: - FT: Growth Capital	A: 20000000 MR: - FA: $20 million FAN: 20000000	D: 2026-03-11 FD: 2026-03-11	1 investors

Growth Capital Latest

2026-03-11

$20.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Scott Russell

President, Chief Executive Officer

A

Amir Belson

Founder, Chief Technology Officer

M

Mark Caires

Chief Financial Officer

L

Laura Brenton

Senior Vice President, Clinical and Medical Affairs

S

Stephen Kleshinski

Senior Vice President, Research

E

Eric Storne

Vice President, Marketing and Clinical Relations

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

Emboline, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised